ASB Consultores’s Sanofi SNY Stock Holding History

ASB Consultores’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-7,696	Closed	-$374K	–	278
2024 Q1	$374K	Buy	+7,696	New	+$376K	0.1%	162
2023 Q2	–	Sell	-4,348	Closed	-$237K	–	204
2023 Q1	$237K	Hold	4,348	–	–	0.1%	162
2022 Q4	$211K	Buy	+4,348	New	+$191K	0.09%	179

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ASB Consultores's SNY Position: Q2 2024 in Review

ASB Consultores sold out of Sanofi (SNY) in Q2 2024, closing a stake of 7,696 shares — an estimated $374K sold.

ASB Consultores first reported a position in SNY in Q4 2022 and held it in 3 quarters. The position peaked at $374K in Q1 2024. 728 funds tracked by Wall St. Rank hold SNY as of Q2 2024.

ASB Consultores reported no remaining Sanofi position as of Q2 2024 after selling out during the quarter.
ASB Consultores sold 7,696 Sanofi shares in Q2 2024, an estimated $374K.
ASB Consultores first reported a position in Sanofi in Q4 2022 and held it in 3 quarters.
ASB Consultores's Sanofi position peaked at $374K in Q1 2024.
728 funds tracked by Wall St. Rank held Sanofi as of Q2 2024.

Based on ASB Consultores's 13F filing for Q2 2024, filed 12 Aug 2024.